Study guide
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique
Key Takeaways Explain This Topic AI
The conjunctival sac holds only about 7 to 10 microlitres, while a typical eye drop is 30 to 50 microlitres.
Punctal occlusion or gentle lid closure for one to two minutes increases ocular absorption and reduces systemic absorption.
When two drops are needed, wait at least five minutes so the second does not wash out the first.
Drops are instilled before ointments, because ointment blocks absorption of anything applied after it.
A complete prescription states drug, concentration, route, eye, frequency, duration and quantity.
Last updated: September 2026
Routes of ocular drug delivery
Route Advantages Disadvantages
Topical drops Simple, patient-administered, high local concentration, minimal systemic exposure if used correctly Very short contact time, poor posterior segment penetration, compliance-dependent, preservative toxicity with chronic use
Ointments Long contact time, good for overnight and for children, lubricating, protects the surface Blurs vision , cosmetically messy, may impede the absorption of drops applied afterwards
Gels / viscous solutions Longer contact than drops with less blur than ointment Transient blur, can leave debris on lashes
Sustained-release inserts and punctal plugs with drug Steady delivery, removes the compliance problem Can be extruded or lost, foreign body sensation, cost
Subconjunctival injection High anterior segment concentration, bypasses the corneal barrier Painful, requires a clinician, local haemorrhage
Sub-Tenon injection Good posterior concentration without entering the eye Chemosis, ptosis, rare globe perforation
Intravitreal injection The only reliable way to achieve therapeutic posterior segment levels for anti-VEGF and antibiotics Endophthalmitis risk , retinal detachment, raised pressure, requires strict asepsis
Systemic (oral / intravenous) Reaches both eyes and the orbit; necessary for orbital cellulitis, giant cell arteritis, systemic disease Systemic side effects, drug interactions, the blood-ocular barrier limits intraocular levels
The blood-ocular barriers — the blood-aqueous and blood-retinal barriers — are why systemic drugs often fail to reach therapeutic intraocular levels and why intravitreal injection exists. Inflammation breaks those barriers down, which is why systemic antibiotics penetrate an inflamed eye better than a quiet one.
The arithmetic of a drop
The conjunctival sac holds about 7 to 10 microlitres . A commercial eye drop is typically 30 to 50 microlitres . Most of a drop therefore overflows onto the cheek or drains down the nasolacrimal duct within seconds .
Three consequences follow directly and all are examinable:
A second drop of the same medication immediately after the first is wasted , because there is no space for it.
When two different drops are prescribed, wait at least five minutes between them, or the second washes out the first.
Drug that drains down the nasolacrimal duct is absorbed across the highly vascular nasal mucosa directly into the systemic circulation , bypassing first-pass hepatic metabolism. This is why a topical beta-blocker can cause bronchospasm and bradycardia.
Punctal occlusion — pressing gently over the medial canthus for one to two minutes after instillation — or simply gentle lid closure for the same period, both increases ocular absorption (by prolonging contact) and reduces systemic absorption (by preventing nasolacrimal drainage). It is a free intervention that every patient on a chronic drop should be taught.
Correct instillation technique
Drops:
Wash hands.
Check the drug, concentration, expiry date and the eye — the same five-rights discipline as any medication.
Ask the patient to tilt the head back or lie back, and to look up.
Gently pull the lower lid down to form a pocket in the inferior fornix.
Hold the bottle above the eye without touching the lashes, lid or globe — contact contaminates the bottle and can abrade the cornea.
Instil one drop into the fornix, not onto the cornea (a drop landing on the cornea is uncomfortable and triggers reflex tearing and blinking that expels it).
Ask the patient to close the eye gently — not squeeze — and apply punctal occlusion for one to two minutes .
Blot excess from the lid with a tissue.
Record the drug, concentration, eye, time and who instilled it.
Ointments: discard the first small bead, then lay a ribbon of about 1 cm along the inferior fornix from the nasal to the temporal side, ask the patient to close the eye and roll it around, and warn about blurred vision. Drops first, ointment last — the ointment forms a barrier that impedes anything applied after it.
Common errors: touching the bottle tip to the eye or lashes, instilling multiple drops "to be sure," letting the drop land on the cornea, the patient squeezing the lids so the drop is expelled, failing to wait between different medications, and failing to teach punctal occlusion.
Patients who cannot instil their own drops — tremor, arthritis, poor vision, cognitive impairment — are a major hidden cause of apparent treatment failure. Ask the patient to demonstrate rather than describe their technique, and consider drop aids, a carer, or a simplified regimen.
Components of a medication prescription
The blueprint names "describe the components of a medical prescription" as an explicit task. A complete ophthalmic prescription contains:
- Patient name, date of birth and address
- Date of issue
- Drug name — generic preferred, to avoid brand confusion
- Concentration / strength — for example 0.5%, 2 mg/mL
- Dosage form — solution, suspension (must be shaken), ointment, gel
Route and eye — right eye, left eye, both eyes; the blueprint's five-domain history and the prescription both depend on unambiguous laterality
- Frequency — written out ("four times daily"), not QD or QID abbreviations that are on the do-not-use list
- Duration or total quantity , and the number of refills
- Specific instructions — shake well, refrigerate, taper schedule, use with punctal occlusion
- Prescriber name, signature, licence or registration number and contact details
Safety conventions: always a leading zero (0.5%), never a trailing zero (write 1%, not 1.0%), write out unit rather than U, and write the frequency in words. Suspensions such as many steroid preparations must be shaken before every use or the delivered dose varies enormously.
Cap colour conventions are a practical aid, standardised in the United States and widely used elsewhere, though they should never substitute for reading the label:
- Cap colour Class
- Red Mydriatics and cycloplegics
- Green Miotics
- Yellow or blue Beta-blockers
- Orange Carbonic anhydrase inhibitors
- Purple / violet Adrenergic agonists
- Turquoise Prostaglandin analogues
- Tan Anti-infectives
- Pink Corticosteroids and anti-inflammatories
- Grey Non-steroidal anti-inflammatory drugs